Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
37%
upside
23 price targets
|
0
%
|
|
|
|
37%
upside
11 price targets
|
0
%
|
|
|
|
37%
upside
7 price targets
|
0
%
|
|
|
429
Agios Pharmaceuticals
AGIO
$1.55B
|
37%
upside
8 price targets
|
0
%
|
|
|
37%
upside
3 price targets
|
0
%
|
|
|
|
37%
upside
26 price targets
|
0
%
|
|
|
|
36%
upside
6 price targets
|
0
%
|
|
|
|
36%
upside
3 price targets
|
0
%
|
|
|
|
36%
upside
3 price targets
|
0
%
|
|
|
|
36%
upside
6 price targets
|
0
%
|
|
|
436
Riskified
RSKD
$660M
|
36%
upside
3 price targets
|
0
%
|
|
|
36%
upside
3 price targets
|
0
%
|
|
|
|
36%
upside
9 price targets
|
0
%
|
|
|
|
36%
upside
11 price targets
|
0
%
|
|
|
|
36%
upside
7 price targets
|
0
%
|
|
|
|
36%
upside
6 price targets
|
0
%
|
|
|
|
35%
upside
7 price targets
|
0
%
|
|
|
|
35%
upside
4 price targets
|
0
%
|
|
|
|
35%
upside
5 price targets
|
0
%
|
|
|
|
35%
upside
5 price targets
|
0
%
|
|
|
|
35%
upside
9 price targets
|
0
%
|
|
|
|
35%
upside
5 price targets
|
0
%
|
|
|
|
35%
upside
3 price targets
|
0
%
|
|
|
|
35%
upside
3 price targets
|
0
%
|
|
|
|
34%
upside
11 price targets
|
0
%
|
|